Emily Podany MD
@podanymd.bsky.social
Third year heme/onc fellow at Washington University | future breast oncologist | MPHS student | health disparities and implementation science
❤️ narrative medicine, hiking, reading, my kids, supporting women in medicine. All opinions my own.
❤️ narrative medicine, hiking, reading, my kids, supporting women in medicine. All opinions my own.
Despite treatment advances, we also found that Black patients with metastatic breast cancer continue to have shorter survival compared to White patients, measured from time of ctDNA. This reflects the persistent and striking nationwide racial outcomes disparity in breast cancer. (4/5)
February 28, 2025 at 1:12 PM
Despite treatment advances, we also found that Black patients with metastatic breast cancer continue to have shorter survival compared to White patients, measured from time of ctDNA. This reflects the persistent and striking nationwide racial outcomes disparity in breast cancer. (4/5)
We found racial differences in variant frequency - higher rates of GATA3 and CCND2 variants in Black patients with MBC - by ctDNA which were validated in a large real-world cohort. But no differences in the targetable mutation PIK3CA, so we studied treatment equity next. (2/5)
February 28, 2025 at 1:12 PM
We found racial differences in variant frequency - higher rates of GATA3 and CCND2 variants in Black patients with MBC - by ctDNA which were validated in a large real-world cohort. But no differences in the targetable mutation PIK3CA, so we studied treatment equity next. (2/5)